Evaluation of immunomodulatory effects of macrolide antibiotics

Evaluation of immunomodulatory effects of macrolide antibiotics - Evaluation of immunomodulatory effects of macrolide antibiotics

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009423

Enrollment

Registered

2012-11-28

Start date

2012-11-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

macrolide antibiotics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteer

Exclusion criteria

Exclusion criteria: (1) Those who have a past hisotry of hypersensitivity to macrolide antibiotics (2) Those who take any medications (3) The person under pregnancy or breast-feeding (4) A person aged 20 and below (5) Those who have symptoms of diarrhea and constipation (6) Those who are not consulting the medical examination in one year before this clinical study registration (7) Those who admitted electrocardiographic abnormality by the prior medical examination (8) Those who have renal dysfunction(creatinine clearance is 30 or less mL/min) (9) Those who have liver dysfunction by the prior medical examination (AST or ALT is 40 or more IU/l) (10) Those who judged as unsuitable by a doctor

Design outcomes

Primary

Measure	Time frame
cell differentiation	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026